Tag: Drug treatment

In the United States, the prevalence of polypharmacy (taking five or more medications) increased from 8.2% in 1999–2000 to 15% in 2011–2012, highlighting the need to understand alternative approaches [1.7.2]. So, **what is monotherapy?** It's a treatment strategy using a single drug to manage a condition.

In 2020, the U.S. Food and Drug Administration (FDA) approved teprotumumab (brand name Tepezza) as the first and only medication specifically for treating Thyroid Eye Disease (TED). This was a major breakthrough for a condition that had previously lacked targeted, non-surgical drug options. For patients wondering what is the new drug for TED, Tepezza represents a targeted, non-surgical advancement in treatment.